Dottikon ES Holding AG (LON:0ACK)

Market Cap	4.60B +74.0%
Revenue (ttm)	403.91M +28.3%
Net Income	112.86M +60.2%
EPS	8.17 +60.2%
Shares Out	n/a
PE Ratio	40.72
Forward PE	38.51
Dividend	n/a
Ex-Dividend Date	n/a

Volume	160
Average Volume	930
Open	359.00
Previous Close	364.93
Day's Range	350.00 - 360.00
52-Week Range	166.40 - 384.50
Beta	1.08
RSI	43.80
Earnings Date	May 29, 2026

About Dottikon ES Holding AG

Dottikon ES Holding AG manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical maceutic industries in Europe, Switzerland, the United States, and Asia. The company’s chemicals and intermediates include amines, anilines, azaindoles, benzimidazoles, benzoic acid derivatives, benzyl compounds, boron building blocks, chiral compounds, cyclohexane derivatives, cyclopropyl building blocks, indazoles, indoles, N-heterocycles, nitrate esters, nitroaromatic compound...

• Industry: Industrial Organic Chemicals
• Founded: 1913
• Employees: 875
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0ACK

Financial Performance

In fiscal year 2025, Dottikon ES Holding AG's revenue was 392.68 million, an increase of 17.93% compared to the previous year's 332.98 million. Earnings were 105.58 million, an increase of 30.95%.

Financial numbers in CHF